Skip to content

New formulation of nelfinavir clears key hurdle on road to EU approval

Once-daily topical tablet as effective as systemic drugs for oral thrush

Atazanavir shown to boost amprenavir levels

Leading AIDS experts criticise major US vaccine trial

Roche stalls second generation fusion inhibitor, citing formulation problems

Looking forward to 2004: microbicide and ARV prevention prospects

Looking forward to 2004: HIV vaccine prospects

Looking forward to 2004: treatment for hepatitis C

Tipranavir now available for emergency use in UK